Chronos Archive seal
The Human Record

Jack London

Case HR-ET010 · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
January 12, 1876 – November 22, 1916
Synthetic DOB
1987-01-12
Index visit
2026-08-04 at age 39
Synthetic MRN
HR-ET010-SYN

Teaching objective: Alcohol use disorder with chronic kidney disease and hypertension in a working writer: a 39-year-old novelist who writes a thousand words every morning on his ranch comes in tired, with swollen ankles, and is found to have a blood pressure of 158/98, an eGFR of 43 and albumin in the urine, and to drink heavily. The episode covers the AUDIT, the DSM-5-TR criteria and PEth; liver tests, FIB-4 and elastography; outpatient withdrawal management with a withdrawal-risk score and thiamine; medicine for alcohol use disorder chosen with kidney function in mind (naltrexone, with acamprosate needing a lower dose at his creatinine clearance and avoided below 30 mL/min); CKD staging by KDIGO 2024 with eGFR and urine albumin, the cause (hypertension and two years of daily naproxen, without stones or gout), ultrasound, the kidney failure risk equation and mineral tests; blood pressure under KDIGO 2021 and the 2025 AHA/ACC guideline with an angiotensin receptor blocker at the maximum dose and potassium and creatinine checks; an SGLT2 inhibitor once he is abstinent, because heavy drinking raises the risk of ketoacidosis; analgesic and opioid safety, with no NSAIDs, a lower acetaminophen limit and naltrexone's opioid blockade; the safety assessment and lethal-means counseling; tobacco; vaccinations in kidney and liver disease; and a plan that protects his morning writing hours.

Historical timeline

DateEventClaims
January 12, 1876Born in San Francisco as John Griffith Chaney; raised by his mother and his stepfather, John London.CLM-0001
1891 to 1894Works from boyhood as an oyster pirate, fish patrolman, seaman and tramp.CLM-0002
1897 to 1898Klondike gold rush; comes home with scurvy.CLM-0003
April 7, 1900Marries; two daughters are born in 1901 and 1902; divorced in 1905, he marries again in November 1905.CLM-0016
1903The Call of the Wild brings international fame; writes 1,000 words a day for the rest of his life.CLM-0004
1905Buys the first land of his ranch at Glen Ellen.CLM-0005
April 23, 1907Sails on the Snark; sores, swollen peeling hands and a silvery skin in the South Pacific; gives up the voyage in Australia.CLM-0006, CLM-0007
July 1913Appendectomy; serious kidney damage found.CLM-0009
August 22, 1913Wolf House burns; John Barleycorn is published the same year.CLM-0005, CLM-0008
April 1914War correspondent at Vera Cruz; ill with dysentery and rheumatism.CLM-0010
July 22, 1915Returns from five months in Hawaii; sails there again on December 16, 1915.CLM-0011
November 22, 1916Dies at his ranch at 40 of uraemia following renal colic; he had refused his doctors' advice to stop drinking and change his habits. A later story of a morphine overdose or suicide is disputed.CLM-0012, CLM-0013, CLM-0014, CLM-0015

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D He was born on January 12, 1876, in San Francisco, and his birth certificate named him John Griffith Chaney. His mother, Flora Wellman, had lived with William Chaney, an astrologer, who left before the birth; she married John London, who adopted and raised the boy. confirmed Jack London: A Brief Biography (Education Resources, History on Jack London) supports
Leal L. The Life of Jack London (docent presentation text and supplemental information, 2017) supports
Stumpf A, Leal L, Hayes G, Houghton L. Interpreting the History of Jack London (docent presentation, 2008, revised 2018) supports
HISTMED Master Roster v3 context
D He grew up poor and worked from boyhood: an oyster pirate at 15, on the fish patrol at 16, an able-bodied seaman at 17, and a tramp crossing America at 18, when he spent a month in jail.
Anchors the social history of a man who rose from poverty.
confirmed Stumpf A, Leal L, Hayes G, Houghton L. Interpreting the History of Jack London (docent presentation, 2008, revised 2018) supports
D He went to the Klondike gold fields in 1897, at 21, and came home with very little after suffering scurvy.
Past nutritional illness; no lasting effect is used in the modern episode.
confirmed Leal L. The Life of Jack London (docent presentation text and supplemental information, 2017) supports
Stumpf A, Leal L, Hayes G, Houghton L. Interpreting the History of Jack London (docent presentation, 2008, revised 2018) supports
D He became internationally famous with The Call of the Wild (1903) and The Sea Wolf (1904), completed more than 50 books between 1900 and 1916, was at his peak the highest paid writer in the United States, and pushed to write 1,000 words a day wherever he was.
Anchors the modern writing schedule.
confirmed Jack London: A Brief Biography (Education Resources, History on Jack London) supports
Stumpf A, Leal L, Hayes G, Houghton L. Interpreting the History of Jack London (docent presentation, 2008, revised 2018) supports
D From 1905 he bought land at Glen Ellen in the Sonoma Valley and built up his Beauty Ranch; Wolf House, his nearly finished stone and redwood home, burned on August 22, 1913, a crushing financial loss. The loss left him depressed, but he forced himself back to work.
Anchors the setting, the financial pressure and the social history; the word 'depressed' is the park's, not a diagnosis.
confirmed Jack London: A Brief Biography (Education Resources, History on Jack London) supports
Jack London State Historic Park supports
Stumpf A, Leal L, Hayes G, Houghton L. Interpreting the History of Jack London (docent presentation, 2008, revised 2018) supports
D On the voyage of his yacht Snark through the South Pacific (1907 to 1909), in the Solomon Islands he had sores that a physician in Fiji called yaws and a missionary said were not; his hands swelled and peeled and his toenails thickened, a malady the Australian specialists could not name; he spent five weeks in hospital in Australia, gave up the voyage, and blamed tropical light. He also had a 'silvery skin' that doctors called by old names for leprosy, which cleared without treatment in California.
His own published account, recorded as he gave it; the modern diagnosis of these conditions is not settled (CLM-0007).
confirmed London J. The Cruise of the Snark (Project Gutenberg eBook #2512) supports
Stumpf A, Leal L, Hayes G, Houghton L. Interpreting the History of Jack London (docent presentation, 2008, revised 2018) supports
Jack London: A Brief Biography (Education Resources, History on Jack London) supports
R Physicians writing since have interpreted his illnesses differently: the 'silvery skin' has been read as psoriasis; one review proposed that mercury used to treat yaws damaged his kidneys and caused a dermatitis of the hands, feet and face; others suggested lupus, gout, and the effects of tobacco, alcohol and diet on his blood pressure and kidneys. None is established.
Retrospective and disputed; none is used as a diagnosis for him. The modern episode's kidney disease has its own synthetic cause.
disputed Leal L. The Death of Jack London: Fact and Fiction (2016) supports
Bomback AS, Klemmer PJ. Jack London's "chronic interstitial nephritis": a historical differential diagnosis. Pharos Alpha Omega Alpha Honor Med Soc 2008;71(1):26-30 (PMID 18246783) supports
Bomback AS, Klemmer PJ. Jack London's "mysterious malady". Am J Med 2007;120(5):466-467 (PMID 17466662) supports
Denko CW. Jack London. A modern analysis of his mysterious disease. J Rheumatol 1993;20(10):1760-1763 (PMID 8295191) supports
Aronica JC, Norton SA. The Snark and the Skin: Jack London's Pacific Voyage. JAMA Dermatol 2015;151(9):1016 (PMID 26352126) context
D In John Barleycorn (1913) he wrote of his drinking from the first time he got drunk, at five years old. He held that he was no born alcoholic and had acquired the taste, and described how at the ranch, after writing his thousand words between nine and eleven each morning, he began to take a cocktail before midday dinner and then alone, 'not for the sake of the taste, but for the effect of the drink.'
His own account of heavy drinking, recorded in his words; it anchors the modern alcohol use disorder but does not make a diagnosis for him.
confirmed London J. John Barleycorn (1913) (Project Gutenberg eBook #318) supports
Jack London: A Brief Biography (Education Resources, History on Jack London) context
HISTMED Master Roster v3 context
D In July 1913 he had his appendix removed, and serious kidney damage was found; his physician diagnosed a significant kidney problem at that time.
Anchors the modern chronic kidney disease; the nature of the kidney disease is not documented in the sources read.
confirmed Stumpf A, Leal L, Hayes G, Houghton L. Interpreting the History of Jack London (docent presentation, 2008, revised 2018) supports
Leal L. The Death of Jack London: Fact and Fiction (2016) supports
D In 1914 he went to Vera Cruz as a war correspondent in the Mexican Revolution and was ill with dysentery and rheumatism.
Past illnesses; they anchor his joint pain in the modern episode but no diagnosis is made from them.
confirmed Stumpf A, Leal L, Hayes G, Houghton L. Interpreting the History of Jack London (docent presentation, 2008, revised 2018) supports
Jack London: A Brief Biography (Education Resources, History on Jack London) supports
D He spent February 24 to July 22, 1915, in Hawaii and sailed there again on December 16, 1915; his health was described that year as declining.
Anchors the dates of the modern episode, set at the ranch between the two stays in Hawaii.
confirmed Leal L. The Life of Jack London (docent presentation text and supplemental information, 2017) supports
Stumpf A, Leal L, Hayes G, Houghton L. Interpreting the History of Jack London (docent presentation, 2008, revised 2018) supports
D His doctors urged him to change his work habits and diet, stop all alcohol and get more exercise, and he refused.
Documented history; no undated advice is used in the modern episode.
confirmed Jack London: A Brief Biography (Education Resources, History on Jack London) supports
D He died at his ranch on November 22, 1916, at 40. His death certificate, signed by his own physician, gave the cause as uraemia following renal colic; his physicians' bulletin described a gastro-intestinal type of uraemia, with coma, after he was taken ill in the night.
Documented cause of death; it anchors the modern kidney disease but nothing about his death is used in the modern episode.
confirmed Leal L. The Death of Jack London: Fact and Fiction (2016) supports
Jack London: A Brief Biography (Education Resources, History on Jack London) supports
Stumpf A, Leal L, Hayes G, Houghton L. Interpreting the History of Jack London (docent presentation, 2008, revised 2018) supports
HISTMED Master Roster v3 context
R Whether morphine contributed to his death is disputed. A story that he took his own life began after his death and was spread by a 1938 biographical novel that described empty morphine vials; his attending physicians denied it, and historians, a pharmacist and physicians have argued against it, noting that he had taken morphine for pain for some time and that failing kidneys would have let a usual dose build up.
Disputed; the record takes neither side, and nothing about suicide or overdose is used in the modern episode. Recorded only as later history.
disputed Leal L. The Death of Jack London: Fact and Fiction (2016) supports
D He married Bess Maddern in 1900; their daughters Joan and Bess were born in 1901 and 1902, and the marriage ended in divorce in 1905. He married Charmian Kittredge in November 1905.
Documented family history; no relative has any statement, decision or health fact in the modern episode.
confirmed Stumpf A, Leal L, Hayes G, Houghton L. Interpreting the History of Jack London (docent presentation, 2008, revised 2018) supports
R The roster's leads of depression and probable bipolar disorder are not documented as diagnoses in the sources read.
Not used as diagnoses; the modern episode screens mood with the PHQ-9.
disputed HISTMED Master Roster v3 context
Jack London: A Brief Biography (Education Resources, History on Jack London) context

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Tiredness, ankle swelling and high blood pressure (158/98 mmHg) with a raised creatinine (1.98 mg/dL, eGFR 43) and albumin in the urine (240 mg/g), found at intake; a creatinine of 1.7 mg/dL at an insurance examination about fourteen months ago, by his account; chronicity and cause under evaluation with a nephrology consultation resolved confirmed active CLM-0009
S Chronic kidney disease, stage G3b A2 (eGFR 42 to 43, urine albumin 240 mg/g), most likely from hypertension with a contribution from two years of daily naproxen; kidneys of normal size, without stones or obstruction; urine sediment bland; synthetic modern diagnosis linked to his documented kidney disease active confirmed both_with_link CLM-0009
S Hypertensive chronic kidney disease, untreated until intake active confirmed active CLM-0009
S Alcohol use disorder, severe (seven DSM-5-TR criteria): a bottle of whisky or more most days for years, a morning drink to steady his hands, failed attempts to cut down, and drinking despite knowing it harms his health; AUDIT 27; PEth 410 ng/mL active confirmed active CLM-0008
S Alcohol-associated fatty liver without advanced fibrosis (liver stiffness 7.2 kPa; steatosis on ultrasound); FIB-4 2.28 at intake active confirmed active CLM-0008
S Daily self-directed naproxen for knee and back pain for about two years, stopped at intake; acetaminophen in its place resolved confirmed active CLM-0010
S Cigarette smoking, about ten a day; not ready to stop while he stops drinking active confirmed active CLM-0007
S Right ankle sprain (lateral ligaments, moderate), from stepping into a burrow while walking the pasture; Ottawa ankle rules negative; healed in about four weeks resolved confirmed active

Synthetic outcome measures

GradeDateMeasureResultCoding
S 2026-08-04 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-08-04 Potassium [Moles/volume] in Serum or Plasma 4.6 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-08-04 Carbon dioxide, total [Moles/volume] in Serum or Plasma 22 mmol/L
Reference 22-29 mmol/L
http://loinc.org · 2028-9
S 2026-08-04 Urea nitrogen [Mass/volume] in Serum or Plasma 28 mg/dL (high)
Reference 7-20 mg/dL
http://loinc.org · 3094-0
S 2026-08-04 Creatinine [Mass/volume] in Serum or Plasma 1.98 mg/dL (high)
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2026-08-04 Glucose [Mass/volume] in Serum or Plasma 94 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-08-04 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 43 mL/min/1.73 m² (low)
Reference 45 to 59 is G3a; 30 to 44 is G3b
http://loinc.org · 98979-8
S 2026-08-04 Albumin/Creatinine [Mass Ratio] in Urine 240 mg/g (high)
Reference Below 30 mg/g A1; 30 to 300 A2; above 300 A3
http://loinc.org · 9318-7
S 2026-08-04 Urate [Mass/volume] in Serum or Plasma 8.4 mg/dL (high)
Reference 4-8 mg/dL
http://loinc.org · 3084-1
S 2026-08-04 Calcium [Mass/volume] in Serum or Plasma 9.2 mg/dL
Reference 8.6-10.3 mg/dL
http://loinc.org · 17861-6
S 2026-08-04 Phosphate [Mass/volume] in Serum or Plasma 3.8 mg/dL
Reference 2.5-4.5 mg/dL
http://loinc.org · 2777-1
S 2026-08-04 Parathyrin.intact [Mass/volume] in Serum or Plasma 74 pg/mL (high)
Reference 15-65 pg/mL
http://loinc.org · 2731-8
S 2026-08-04 Hemoglobin [Mass/volume] in Blood 13.6 g/dL
Reference 13-17 g/dL
http://loinc.org · 718-7
S 2026-08-04 MCV [Entitic mean volume] in Red Blood Cells by Automated count 101 fL (high)
Reference 80-100 fL
http://loinc.org · 787-2
S 2026-08-04 Platelets [#/volume] in Blood by Automated count 182 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 2026-08-04 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 68 U/L (high)
Reference 10-40 U/L
http://loinc.org · 1920-8
S 2026-08-04 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 41 U/L
Reference 9-46 U/L
http://loinc.org · 1742-6
S 2026-08-04 Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma 186 U/L (high)
Reference 8-61 U/L
http://loinc.org · 2324-2
S 2026-08-04 Albumin [Mass/volume] in Serum or Plasma 4.1 g/dL
Reference 3.5-5 g/dL
http://loinc.org · 1751-7
S 2026-08-04 Bilirubin.total [Mass/volume] in Serum or Plasma 0.9 mg/dL
Reference 0.2-1.2 mg/dL
http://loinc.org · 1975-2
S 2026-08-04 INR in Platelet poor plasma by Coagulation assay 1
Reference 0.9-1.1
http://loinc.org · 6301-6
S 2026-08-04 Phosphatidylethanol [Mass/volume] in Blood 410 ng/mL (high)
Reference Below 20 ng/mL abstinence or light drinking; above 200 heavy drinking
http://loinc.org · 74661-0
S 2026-08-04 Hemoglobin A1c/Hemoglobin.total in Blood 5.4%
Reference <=5.6%
http://loinc.org · 4548-4
S 2026-08-04 Cholesterol [Mass/volume] in Serum or Plasma 214 mg/dL (high)
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 2026-08-04 Cholesterol in HDL [Mass/volume] in Serum or Plasma 58 mg/dL
Reference >=40 mg/dL
http://loinc.org · 2085-9
S 2026-08-04 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 128 mg/dL
Reference <=129 mg/dL
http://loinc.org · 13457-7
S 2026-08-04 Triglyceride [Mass/volume] in Serum or Plasma 140 mg/dL
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 2026-08-04 Total score [AUDIT] 27 http://loinc.org · 75624-7
S 2026-08-04 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 9 http://loinc.org · 44261-6
S 2026-08-04 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 7 http://loinc.org · 70274-6
S 2026-08-18 Potassium [Moles/volume] in Serum or Plasma 4.9 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-08-18 Creatinine [Mass/volume] in Serum or Plasma 2.04 mg/dL (high)
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2026-08-18 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 42 mL/min/1.73 m² (low)
Reference 45 to 59 is G3a; 30 to 44 is G3b
http://loinc.org · 98979-8
S 2026-08-18 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 49 U/L (high)
Reference 10-40 U/L
http://loinc.org · 1920-8
S 2026-08-18 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 36 U/L
Reference 9-46 U/L
http://loinc.org · 1742-6
S 2026-08-18 Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma 141 U/L (high)
Reference 8-61 U/L
http://loinc.org · 2324-2
S 2026-09-15 Sodium [Moles/volume] in Serum or Plasma 140 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-09-15 Potassium [Moles/volume] in Serum or Plasma 4.8 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-09-15 Carbon dioxide, total [Moles/volume] in Serum or Plasma 23 mmol/L
Reference 22-29 mmol/L
http://loinc.org · 2028-9
S 2026-09-15 Creatinine [Mass/volume] in Serum or Plasma 1.96 mg/dL (high)
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2026-09-15 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 44 mL/min/1.73 m² (low)
Reference 45 to 59 is G3a; 30 to 44 is G3b
http://loinc.org · 98979-8
S 2026-09-15 Albumin/Creatinine [Mass Ratio] in Urine 128 mg/g (high)
Reference Below 30 mg/g A1; 30 to 300 A2; above 300 A3
http://loinc.org · 9318-7
S 2026-09-15 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 34 U/L
Reference 10-40 U/L
http://loinc.org · 1920-8
S 2026-09-15 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 29 U/L
Reference 9-46 U/L
http://loinc.org · 1742-6
S 2026-09-15 Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma 82 U/L (high)
Reference 8-61 U/L
http://loinc.org · 2324-2
S 2026-09-15 Phosphatidylethanol [Mass/volume] in Blood 36 ng/mL (high)
Reference Below 20 ng/mL abstinence or light drinking; above 200 heavy drinking
http://loinc.org · 74661-0
S 2026-09-15 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 24 ng/mL (low)
Reference Below 20 ng/mL deficient; 20 to 29 insufficient
http://loinc.org · 62292-8
S 2026-09-15 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 5 http://loinc.org · 44261-6
S 2026-09-29 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 http://loinc.org · 55758-7
S 2026-10-13 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-10-13 Potassium [Moles/volume] in Serum or Plasma 5 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-10-13 Carbon dioxide, total [Moles/volume] in Serum or Plasma 23 mmol/L
Reference 22-29 mmol/L
http://loinc.org · 2028-9
S 2026-10-13 Creatinine [Mass/volume] in Serum or Plasma 1.95 mg/dL (high)
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2026-10-13 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 44 mL/min/1.73 m² (low)
Reference 45 to 59 is G3a; 30 to 44 is G3b
http://loinc.org · 98979-8
S 2026-10-13 Phosphatidylethanol [Mass/volume] in Blood 8 ng/mL
Reference Below 20 ng/mL abstinence or light drinking; above 200 heavy drinking
http://loinc.org · 74661-0
S 2026-10-27 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-10-27 Potassium [Moles/volume] in Serum or Plasma 4.7 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-10-27 Carbon dioxide, total [Moles/volume] in Serum or Plasma 23 mmol/L
Reference 22-29 mmol/L
http://loinc.org · 2028-9
S 2026-10-27 Urea nitrogen [Mass/volume] in Serum or Plasma 24 mg/dL (high)
Reference 7-20 mg/dL
http://loinc.org · 3094-0
S 2026-10-27 Creatinine [Mass/volume] in Serum or Plasma 2.13 mg/dL (high)
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2026-10-27 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 40 mL/min/1.73 m² (low)
Reference 45 to 59 is G3a; 30 to 44 is G3b
http://loinc.org · 98979-8
S 2026-10-27 Albumin/Creatinine [Mass Ratio] in Urine 96 mg/g (high)
Reference Below 30 mg/g A1; 30 to 300 A2; above 300 A3
http://loinc.org · 9318-7
S 2026-10-27 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 29 U/L
Reference 10-40 U/L
http://loinc.org · 1920-8
S 2026-10-27 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 26 U/L
Reference 9-46 U/L
http://loinc.org · 1742-6
S 2026-10-27 Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma 54 U/L
Reference 8-61 U/L
http://loinc.org · 2324-2
S 2026-10-27 MCV [Entitic mean volume] in Red Blood Cells by Automated count 96 fL
Reference 80-100 fL
http://loinc.org · 787-2
S 2026-10-27 Phosphatidylethanol [Mass/volume] in Blood 6 ng/mL
Reference Below 20 ng/mL abstinence or light drinking; above 200 heavy drinking
http://loinc.org · 74661-0
S 2026-10-27 Total score [AUDIT] 9 http://loinc.org · 75624-7
S 2026-10-27 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 http://loinc.org · 44261-6
S 2026-10-27 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 4 http://loinc.org · 70274-6

Synthetic vital signs

DateMeasureResultLOINCGrade
2026-08-04Body height173 cm8302-2S
2026-08-04Body weight84.2 kg29463-7S
2026-08-04Body mass index (BMI) [Ratio]28.1 kg/m239156-5S
2026-08-04Systolic blood pressure158 mm[Hg]8480-6S
2026-08-04Diastolic blood pressure98 mm[Hg]8462-4S
2026-08-04Heart rate92 /min8867-4S
2026-08-04Respiratory rate16 /min9279-1S
2026-08-04Body temperature36.8 Cel8310-5S
2026-08-04Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
2026-08-18Body height173 cm8302-2S
2026-08-18Body weight83.6 kg29463-7S
2026-08-18Body mass index (BMI) [Ratio]27.9 kg/m239156-5S
2026-08-18Systolic blood pressure146 mm[Hg]8480-6S
2026-08-18Diastolic blood pressure92 mm[Hg]8462-4S
2026-08-18Heart rate84 /min8867-4S
2026-08-18Respiratory rate16 /min9279-1S
2026-08-18Body temperature36.6 Cel8310-5S
2026-08-18Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-09-15Body height173 cm8302-2S
2026-09-15Body weight82.6 kg29463-7S
2026-09-15Body mass index (BMI) [Ratio]27.6 kg/m239156-5S
2026-09-15Systolic blood pressure138 mm[Hg]8480-6S
2026-09-15Diastolic blood pressure86 mm[Hg]8462-4S
2026-09-15Heart rate78 /min8867-4S
2026-09-15Respiratory rate14 /min9279-1S
2026-09-15Body temperature36.6 Cel8310-5S
2026-09-15Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-10-13Body height173 cm8302-2S
2026-10-13Body weight81.4 kg29463-7S
2026-10-13Body mass index (BMI) [Ratio]27.2 kg/m239156-5S
2026-10-13Systolic blood pressure126 mm[Hg]8480-6S
2026-10-13Diastolic blood pressure80 mm[Hg]8462-4S
2026-10-13Heart rate72 /min8867-4S
2026-10-13Respiratory rate14 /min9279-1S
2026-10-13Body temperature36.6 Cel8310-5S
2026-10-13Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-10-27Body height173 cm8302-2S
2026-10-27Body weight80.9 kg29463-7S
2026-10-27Body mass index (BMI) [Ratio]27 kg/m239156-5S
2026-10-27Systolic blood pressure122 mm[Hg]8480-6S
2026-10-27Diastolic blood pressure78 mm[Hg]8462-4S
2026-10-27Heart rate70 /min8867-4S
2026-10-27Respiratory rate14 /min9279-1S
2026-10-27Body temperature36.6 Cel8310-5S
2026-10-27Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-09-29Body height173 cm8302-2S
2026-09-29Body weight82 kg29463-7S
2026-09-29Body mass index (BMI) [Ratio]27.4 kg/m239156-5S
2026-09-29Systolic blood pressure130 mm[Hg]8480-6S
2026-09-29Diastolic blood pressure82 mm[Hg]8462-4S
2026-09-29Heart rate74 /min8867-4S
2026-09-29Respiratory rate14 /min9279-1S
2026-09-29Body temperature36.6 Cel8310-5S
2026-09-29Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-09-01Body height173 cm8302-2S
2026-09-01Body weight83.2 kg29463-7S
2026-09-01Body mass index (BMI) [Ratio]27.8 kg/m239156-5S
2026-09-01Systolic blood pressure142 mm[Hg]8480-6S
2026-09-01Diastolic blood pressure88 mm[Hg]8462-4S
2026-09-01Heart rate88 /min8867-4S
2026-09-01Respiratory rate16 /min9279-1S
2026-09-01Body temperature36.7 Cel8310-5S
2026-09-01Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Structured safety assessment

Current ideation
absent
Intent
absent
Plan
absent
Disposition
Outpatient care with close follow-up. Risk factors reviewed without detail: severe alcohol use disorder, a new chronic illness, financial pressure, mild depressive and anxiety symptoms, and firearms on the ranch. He agreed that the rifle and shotgun will be kept locked in the ranch office safe with the ammunition stored apart, and that he will not handle them after drinking. Chlordiazepoxide is dispensed for five days only, with a daily telephone check. A written safety plan was made with him, and the 988 Suicide & Crisis Lifeline (call or text 988) and the clinic's number were written on a card he carries. Safety is reviewed at every visit

This assessment is synthetic and does not convert historical behavior into a present-day fact.

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

Care-plan goals

GoalTarget dateStatusOutcome
Find out how much kidney function is lost, how long it has been so, and why2026-08-18completedChronic kidney disease G3b A2 from hypertension with naproxen contributing; no stones, obstruction or glomerular disease suspected
Stop drinking safely, and stay stopped2027-02-02activeWithdrawal completed without complications; one evening of drinking at four weeks; abstinent since, with PEth 8 and then 6 ng/mL
Blood pressure below 120 systolic by standardized office measurement if tolerated, and at least below 130/802027-02-02active158/98 to 122/78 at twelve weeks on losartan 100 mg
Urine albumin down by at least 30 percent2026-10-27completed240 to 96 mg/g on losartan and then dapagliflozin
No anti-inflammatory pain medicines, and pain controlled2026-10-27completedNo naproxen since intake; acetaminophen and topical treatment only, including for an ankle sprain
Keep the morning writing hours2026-10-27completedWrote every morning through the twelve weeks except the two days of the worst withdrawal

Interventions

InterventionStatusGuideline
Kidneys and blood pressure: creatinine with eGFR (CKD-EPI 2021), urine albumin-to-creatinine ratio and urinalysis with microscopy, electrolytes and bicarbonate, uric acid, calcium, phosphate and PTH, blood count, HbA1c and a lipid panel once; the earlier insurance creatinine obtained; ultrasound of the kidneys and liver; standardized office blood pressure at every visit and home readingscompletedGL-KDIGO-CKD-2024, GL-KDIGO-BP-2021, GL-CMID-2026
Nephrology consultation to confirm the stage and cause of the kidney disease and advise on blood pressure, an SGLT2 inhibitor, medicines for alcohol use disorder at his kidney function, and pain reliefcompletedGL-KDIGO-CKD-2024, GL-KDIGO-BP-2021
Losartan 50 mg daily from intake, raised to the maximum tolerated dose, with potassium and creatinine two to four weeks after each start or change, accepting a rise in creatinine of up to 30 percent; less saltcompletedGL-KDIGO-BP-2021, GL-AHA-HTN-2025, GL-CMID-2026
Alcohol: AUDIT, DSM-5-TR criteria and PEth with consent; liver tests and FIB-4; a withdrawal-risk score (PAWSS) and outpatient withdrawal with a five-day chlordiazepoxide taper, daily telephone checks and thiamine; addiction-focused counseling with the clinic's addiction medicine team each week and mutual-help meetings if he wishes; PEth and liver tests at follow-upcompletedGL-APA-AUD-2018, GL-SUD-2021, GL-ASAM-AWM-2020, GL-AASLD-NIT-2025
Medicine for alcohol use disorder: naltrexone 50 mg daily, which needs no dose change at his kidney function, with liver tests and a wallet card about opioid blockade; acamprosate not chosen because it needs a lower dose at his creatinine clearance and is avoided below 30 mL/min, and he could not reliably take it three times a daycompletedGL-APA-AUD-2018, GL-SUD-2021, GL-KDIGO-CKD-2024
Liver: ultrasound and vibration-controlled transient elastography for an indeterminate FIB-4; abstinence as the treatmentcompletedGL-AASLD-ALD-2019, GL-AASLD-NIT-2025
SGLT2 inhibitor (dapagliflozin 10 mg daily) once he has been abstinent for some weeks and is eating regularly, because heavy drinking and fasting raise the risk of ketoacidosis; held on days he cannot eat or drink, with potassium and creatinine two to four weeks after starting, accepting an early fall in eGFRcompletedGL-KDIGO-CKD-2024, GL-CMID-2026
Pain and medicine safety: no naproxen, ibuprofen or other oral anti-inflammatory medicines; acetaminophen up to 2,000 mg a day; no opioids or tramadol with kidney disease and in early recovery, and none at all if naltrexone is started; any new medicine checked for kidney dosingcompletedGL-KDIGO-CKD-2024, GL-CMID-2026
Safety: a structured safety assessment, firearms locked with ammunition apart, small supplies of withdrawal medicine, a written safety plan, the 988 Suicide & Crisis Lifeline, and safety review at every visitcompletedGL-SUICIDE-2024, GL-USPSTF-DEP-2023
Work and recovery: keep the morning writing hours from nine to eleven; replace the late-morning drink with a swim or a ride; no alcohol kept in the writing room; PHQ-9 and GAD-7 at intake and follow-upcompletedGL-SUD-2021, GL-USPSTF-DEP-2023
Tobacco: advice to stop, with nicotine replacement or varenicline offered when he is readycompletedGL-USPSTF-TOB-2021

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Jack London: A Brief Biography (Education Resources, History on Jack London) Jack London State Historic Park (Jack London Park Partners) other
SRC-0002 Stumpf A, Leal L, Hayes G, Houghton L. Interpreting the History of Jack London (docent presentation, 2008, revised 2018) Jack London State Historic Park other
SRC-0003 Leal L. The Life of Jack London (docent presentation text and supplemental information, 2017) Jack London State Historic Park other
SRC-0004 Leal L. The Death of Jack London: Fact and Fiction (2016) Jack London State Historic Park other
SRC-0005 London J. The Cruise of the Snark (Project Gutenberg eBook #2512) Project Gutenberg primary
SRC-0006 London J. John Barleycorn (1913) (Project Gutenberg eBook #318) Project Gutenberg primary
SRC-0007 Bomback AS, Klemmer PJ. Jack London's "chronic interstitial nephritis": a historical differential diagnosis. Pharos Alpha Omega Alpha Honor Med Soc 2008;71(1):26-30 (PMID 18246783) The Pharos scholarly
SRC-0008 Bomback AS, Klemmer PJ. Jack London's "mysterious malady". Am J Med 2007;120(5):466-467 (PMID 17466662) The American Journal of Medicine scholarly
SRC-0009 Denko CW. Jack London. A modern analysis of his mysterious disease. J Rheumatol 1993;20(10):1760-1763 (PMID 8295191) The Journal of Rheumatology scholarly
SRC-0010 Aronica JC, Norton SA. The Snark and the Skin: Jack London's Pacific Voyage. JAMA Dermatol 2015;151(9):1016 (PMID 26352126) JAMA Dermatology scholarly
SRC-0011 Jack London State Historic Park California State Parks government
SRC-0012 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the CKD staging (G3b A2) and the attribution to hypertension and naproxen without a biopsy, losartan to the maximum dose with potassium checks, the systolic target, the delay of dapagliflozin until abstinence because of ketoacidosis risk, naltrexone over acamprosate at his kidney function, outpatient chlordiazepoxide withdrawal, the elastography interpretation, no treatment of asymptomatic high uric acid, the analgesic plan and the topical diclofenac for the sprain, the safety assessment and firearm storage, and the vaccinations.
provenance reviewnot_startedSources: Jack London State Historic Park (the biography and three park historian or docent documents, one citing the death certificate and Huntington Library correspondence), California State Parks, his own accounts in The Cruise of the Snark and John Barleycorn (Project Gutenberg), and the PubMed records of Bomback and Klemmer (2007, 2008), Denko (1993) and Aronica and Norton (2015). The Huntington Library, Sonoma State University and Library of Congress pages could not be read. The roster's depression and probable bipolar disorder are not used as diagnoses.
safe messaging reviewnot_startedAlcohol, mood and the disputed morphine and suicide story are marked sensitive. The morphine question is recorded once, plainly, as disputed later history, with neither side adopted, and is not used in the modern episode or shown in the intake documents. His drinking is described in his own published words and the modern alcohol use disorder is synthetic. A structured safety assessment with lethal-means counseling and the 988 line is recorded, and safety is reviewed at every visit. His relatives appear only as documented history; no relative has a role in the modern episode.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.